Archives: Events

Mar
16
Mar
24

The ART of HIV and STI Prevention: Update From CROI 2026

Overview Assessment of Needs This webinar will discuss the latest data on the prevention of HIV and sexually transmitted infections, highlighting new information presented at the 33rd Conference on Retroviruses and Opportunistic Infections (CROI), which was held February 22-25, 2026, in Denver, Colorado. Learning Objectives On completion of this webinar, participants will be (more…)

DETAIL
Mar
26

IAS-USA Dialogue Series: Emerging Infections and Health Threats

IAS–USA Dialogues are spirited, timely conversations on the public health, scientific, and clinical aspects of current urgent outbreaks, including seasonal viruses such as influenza, emerging infectious disease threats in the US and around the world, controversies surrounding trustworthy guidance on vaccinations, and other topics of the day. Registration is now open for our (more…)

DETAIL
Mar
31

Antiretroviral Management of HIV: New Data From CROI 2026

Overview Assessment of Needs This webinar will review current data on the antiretroviral treatment of HIV, including new data presented at the 33rd annual Conference on Retroviruses and Opportunistic Infections (CROI), which will be held February 22-25, 2026, in Denver, Colorado. Learning Objectives On completion of this webinar, participants will be able to: (more…)

DETAIL
Apr
15

Immunization Guidance for People With HIV: Where Do You Go and Who Do You Trust?

Overview Assessment of Needs Vaccination plays a crucial role in preventing infection-related illness and death among immunocompromised populations, including individuals with HIV. Immunization recommendations for people with HIV can be complex and are frequently updated as new evidence emerges. In addition, ongoing vaccination controversies and the politicization of public health guidance have contributed (more…)

DETAIL
Apr
22
Apr
28

Promises and Complications of Doxy-PEP for the Prevention of Sexually Transmitted Infections in People With HIV: Complex Cases

Overview Assessment of Needs Doxycycline postexposure prophylaxis (doxy-PEP) has emerged as a promising strategy to reduce the incidence of bacterial sexually transmitted infections (STIs) among people with HIV. As uptake increases, clinicians are increasingly encountering complex and challenging clinical scenarios that extend beyond standard guidance. This webinar will review the current evidence base (more…)

DETAIL
May
1

TAM Publication – March/April 2026; Volume 34, Issue 2

Selected Highlights of the 2026 Conference on Retroviruses and Opportunistic Infections CROI 2026: Basic Science Highlights From the 2026 Conference on Retroviruses and Opportunistic Infections Mario Stevenson, PhD CROI 2026: Neuro-HIV at the Crossroads of Coinfections, Reservoirs, ART, and Comorbidities Michael J. Corley, MA PhD, Sarah B. Joseph, PhD, Phillip Chan, MBChB, PhD CROI 2026: (more…)

DETAIL
May
5

GLP-1 Receptor Agonists in People With HIV: Emerging Evidence and Clinical Implications

Overview Assessment of Needs Weight gain and obesity are increasingly prevalent among people with HIV (PWH), and excess adiposity likely contributes to the growing burden of cardiometabolic disease in this population. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as an effective therapeutic option for weight management, demonstrating substantial weight reduction and associated (more…)

DETAIL